{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T05:54:24Z","timestamp":1793166864237,"version":"4.5.0"},"reference-count":122,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,1,21]],"date-time":"2016-01-21T00:00:00Z","timestamp":1453334400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Gastroenterol Hepatol"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1038\/nrgastro.2015.226","type":"journal-article","created":{"date-parts":[[2016,1,21]],"date-time":"2016-01-21T01:24:54Z","timestamp":1453339494000},"page":"175-185","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":156,"title":["Cystic fibrosis from the gastroenterologist's perspective"],"prefix":"10.1038","volume":"13","author":[{"given":"Chee Y.","family":"Ooi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter R.","family":"Durie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,21]]},"reference":[{"key":"BFnrgastro2015226_CR1","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1126\/science.2475911","volume":"245","author":"JR Riordan","year":"1989","unstructured":"Riordan, J. R. et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245, 1066 (1989).","journal-title":"Science"},{"key":"BFnrgastro2015226_CR2","first-page":"21","volume-title":"Cystic Fibrosis","author":"S Walters","year":"2007","unstructured":"Walters, S. & Mehta, A. in Cystic Fibrosis 3rd edn (eds Hodson, M. et al.) 21\u201345 (Edward Arnold Ltd, 2007)."},{"key":"BFnrgastro2015226_CR3","unstructured":"Cystic Fibrosis Foundation. Patient Registry Annual Data Report. [online] , (2013)."},{"key":"BFnrgastro2015226_CR4","unstructured":"Cystic Fibrosis Canada. 2013 annual report. The Canadian Cystic Fibrosis Patient Data Registry. [online] , (2013)."},{"key":"BFnrgastro2015226_CR5","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1056\/NEJM199502233320803","volume":"332","author":"JP Neglia","year":"1995","unstructured":"Neglia, J. P. et al. The risk of cancer among patients with cystic fibrosis. N. Engl. J. Med. 332, 494\u2013499 (1995).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro2015226_CR6","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1093\/jnci\/95.5.381","volume":"95","author":"P Maisonneuve","year":"2003","unstructured":"Maisonneuve, P. et al. Cancer risk in nontransplanted and transplanted cystic fibrosis patients: a 10-year study. J. Natl Cancer Inst. 95, 381\u2013387 (2003).","journal-title":"J. Natl Cancer Inst."},{"key":"BFnrgastro2015226_CR7","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1093\/jnci\/djs481","volume":"105","author":"P Maisonneuve","year":"2013","unstructured":"Maisonneuve, P. et al. Cancer risk in cystic fibrosis: a 20-year nationwide study from the United States. J. Natl Cancer Inst. 105, 122\u2013129 (2013).","journal-title":"J. Natl Cancer Inst."},{"key":"BFnrgastro2015226_CR8","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1378\/chest.126.4.1215","volume":"126","author":"K Gilljam","year":"2004","unstructured":"Gilljam, K. et al. Clinical manifestations of cystic fibrosis among patients diagnosed in adulthood. Chest 126, 1215\u20131224 (2004).","journal-title":"Chest"},{"key":"BFnrgastro2015226_CR9","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1053\/j.gastro.2010.09.046","volume":"140","author":"CY Ooi","year":"2011","unstructured":"Ooi, C. Y. et al. Type of CFTR mutation determines risk of pancreatitis in patients with cystic fibrosis. Gastroenterology 140, 153\u2013161 (2011).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2015226_CR10","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1136\/thoraxjnl-2011-201454","volume":"67","author":"CY Ooi","year":"2012","unstructured":"Ooi, C. Y. et al. Comparing the American and European diagnostic guidelines for cystic fibrosis: same disease, different language? Thorax 67, 618\u2013624 (2012).","journal-title":"Thorax"},{"key":"BFnrgastro2015226_CR11","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1136\/thoraxjnl-2013-203832","volume":"69","author":"CY Ooi","year":"2014","unstructured":"Ooi, C. Y. et al. Does extensive genotyping and nasal potential difference testing clarify the diagnosis of cystic fibrosis among patients with single-organ manifestations of cystic fibrosis? Thorax 69, 254\u2013260 (2014).","journal-title":"Thorax"},{"key":"BFnrgastro2015226_CR12","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.jcf.2012.05.001","volume":"11","author":"CY Ooi","year":"2012","unstructured":"Ooi, C. Y. & Durie, P. Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in pancreatitis. J. Cyst. Fibros. 11, 355\u2013362 (2012).","journal-title":"J. Cyst. Fibros."},{"key":"BFnrgastro2015226_CR13","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1056\/NEJMoa1105185","volume":"365","author":"BW Ramsey","year":"2011","unstructured":"Ramsey, B. W. et al. A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. N. Engl. J. Med. 365, 1663\u20131672 (2011).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro2015226_CR14","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1056\/NEJMoa1409547","volume":"373","author":"CE Wainwright","year":"2015","unstructured":"Wainwright, C. E. et al. Lumacaftor\u2013ivacaftor in patients with cystic fibrosis homozygous for Phe508del CFTR. N. Engl. J. Med. 373, 220\u2013231 (2015).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro2015226_CR15","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/humu.1380020402","volume":"2","author":"AL Beaudet","year":"1993","unstructured":"Beaudet, A. L. & Tsui, L.-C. A suggested nomenclature for designating mutations. Hum. Mutat. 2, 245\u2013248 (1993).","journal-title":"Hum. Mutat."},{"key":"BFnrgastro2015226_CR16","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.jcf.2014.01.007","volume":"13","author":"V Terlizzi","year":"2014","unstructured":"Terlizzi, V. et al. Prediction of acute pancreatitis risk based on PIP score in children with cystic fibrosis. J. Cyst. Fibros. 13, 579\u2013584 (2014).","journal-title":"J. Cyst. Fibros."},{"key":"BFnrgastro2015226_CR17","doi-asserted-by":"publisher","unstructured":"Dupuis, A. et al. Prevalence of meconium ileus (MIP) marks the severity of mutations of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. http:\/\/dx.doi.org\/10.1038\/gim.2015.79 (2015).","DOI":"10.1038\/gim.2015.79"},{"issue":"Suppl. 1","key":"BFnrgastro2015226_CR18","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1152\/physrev.1999.79.1.S23","volume":"79","author":"DN Sheppard","year":"1999","unstructured":"Sheppard, D. N. & Welsh, M. J. Structure and function of the cystic fibrosis transmembrane conductance regulator chloride channel. Physiol. Rev. 79 (Suppl. 1), S23\u2013S45 (1999).","journal-title":"Physiol. Rev."},{"key":"BFnrgastro2015226_CR19","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/301421a0","volume":"301","author":"PM Quinton","year":"1983","unstructured":"Quinton, P. M. Chloride impermeability in cystic fibrosis. Nature 301, 421\u2013422 (1983).","journal-title":"Nature"},{"key":"BFnrgastro2015226_CR20","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1126\/science.7543698","volume":"269","author":"MJ Stutts","year":"1995","unstructured":"Stutts, M. J. et al. CFTR as a cAMP-dependent regulator of sodium channels. Science 269, 847\u2013850 (1995).","journal-title":"Science"},{"key":"BFnrgastro2015226_CR21","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1126\/science.7543698","volume":"269","author":"MJ Stutts","year":"1995","unstructured":"Stutts, M. J. CFTR as a cAMP-regulator of Na+ channels. Science 269, 847\u2013850 (1995).","journal-title":"Science"},{"key":"BFnrgastro2015226_CR22","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1007\/s10620-012-2209-1","volume":"58","author":"D Gelfond","year":"2013","unstructured":"Gelfond, D. et al. Intestinal pH and gastrointestinal transit profiles in cystic fibrosis patients measured by wireless motility capsule. Dig. Dis. Sci. 58, 2275\u20132281 (2013).","journal-title":"Dig. Dis. Sci."},{"key":"BFnrgastro2015226_CR23","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1172\/JCI38662","volume":"119","author":"MA Garcia","year":"2009","unstructured":"Garcia, M. A., Yang, N. & Quinton, P. M. Normal mouse intestinal mucus release requires cystic fibrosis transmembrane regulator-dependent bicarbonate secretion. J. Clin. Invest. 119, 2613\u20132622 (2009).","journal-title":"J. Clin. Invest."},{"issue":"Suppl. 2","key":"BFnrgastro2015226_CR24","doi-asserted-by":"publisher","first-page":"S86","DOI":"10.1016\/S1569-1993(11)60014-3","volume":"10","author":"C Bombieri","year":"2011","unstructured":"Bombieri, C. et al. Recommendations for the classification of diseases as CFTR-related disorders. J. Cyst. Fibros. 10 (Suppl. 2), S86\u2013S102 (2011).","journal-title":"J. Cyst. Fibros."},{"key":"BFnrgastro2015226_CR25","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1136\/gut.52.8.1159","volume":"52","author":"N Ahmed","year":"2003","unstructured":"Ahmed, N. et al. Molecular consequences of cystic fibrosis transmembrane regulator (CFTR) gene mutations in the exocrine pancreas. Gut 52, 1159\u20131164 (2003).","journal-title":"Gut"},{"key":"BFnrgastro2015226_CR26","first-page":"1178","volume":"50","author":"P Kristidis","year":"1992","unstructured":"Kristidis, P. et al. Genetic determination of exocrine pancreatic function in cystic fibrosis. Am. J. Hum. Genet. 50, 1178\u20131184 (1992).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrgastro2015226_CR27","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1053\/gast.2002.37042","volume":"123","author":"C Durno","year":"2002","unstructured":"Durno, C. et al. Genotype and phenotype correlations in patients with cystic fibrosis and pancreatitis. Gastroenterology 123, 1857\u20131864 (2002).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2015226_CR28","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1097\/MEG.0b013e3282f36d04","volume":"20","author":"A Augarten","year":"2008","unstructured":"Augarten, A. et al. The changing face of the exocrine pancreas in cystic fibrosis: the correlation between pancreatic status, pancreatitis and cystic fibrosis genotype. Eur. J. Gastroenterol. Hepatol. 20, 164\u2013168 (2008).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"BFnrgastro2015226_CR29","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/S0022-3476(82)80501-5","volume":"100","author":"K Gaskin","year":"1982","unstructured":"Gaskin, K. et al. Improved respiratory prognosis in CF patients with normal fat absorption. J. Pediatr. 100, 857\u2013862 (1982).","journal-title":"J. Pediatr."},{"key":"BFnrgastro2015226_CR30","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1136\/gut.2004.062786","volume":"56","author":"M Wilschanski","year":"2007","unstructured":"Wilschanski, M. & Durie, P. R. Patterns of GI disease in adulthood associated with mutations in the CFTR gene. Gut 56, 1153\u20131163 (2007).","journal-title":"Gut"},{"key":"BFnrgastro2015226_CR31","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1016\/S0002-9440(10)61117-0","volume":"160","author":"PJ Lewindon","year":"2002","unstructured":"Lewindon, P. J. et al. The role of hepatic stellate cells and transforming growth factor-\u00df1 in cystic fibrosis liver disease. Am. J. Pathol. 160, 1705\u20131715 (2002).","journal-title":"Am. J. Pathol."},{"key":"BFnrgastro2015226_CR32","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/hep.1840160215","volume":"16","author":"A Linblad","year":"1992","unstructured":"Linblad, A., Hultcrantz, R. & Strandvik, B. Bile-duct destruction and collagen deposition: a prominent ultrastructural feature of the liver in cystic fibrosis. Hepatology 16, 372\u2013381 (1992).","journal-title":"Hepatology"},{"key":"BFnrgastro2015226_CR33","doi-asserted-by":"publisher","first-page":"e0116967","DOI":"10.1371\/journal.pone.0116967","volume":"10","author":"T Flass","year":"2015","unstructured":"Flass, T. et al. Intestinal lesions are associated with altered intestinal microbiome and are more frequent in children and young adults with cystic fibrosis and cirrhosis. PLoS ONE 10, e0116967 (2015).","journal-title":"PLoS ONE"},{"key":"BFnrgastro2015226_CR34","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1001\/jama.2009.1295","volume":"302","author":"JR Bartlett","year":"2009","unstructured":"Bartlett, J. R. et al. Genetic modifiers of liver disease in cystic fibrosis. JAMA 302, 1076\u20131083 (2009).","journal-title":"JAMA"},{"key":"BFnrgastro2015226_CR35","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/hep.24014","volume":"53","author":"PJ Lewindon","year":"2011","unstructured":"Lewindon, P. J. et al. Importance of hepatic fibrosis in cystic fibrosis and the predictive value of liver biopsy. Hepatology 53, 193\u2013201 (2011).","journal-title":"Hepatology"},{"key":"BFnrgastro2015226_CR36","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1002\/hep.24183","volume":"53","author":"P Witters","year":"2011","unstructured":"Witters, P. et al. Noncirrhotic presinusoidal portal hypertension is common in cystic fibrosis-associated liver disease. Hepatology 53, 1064\u20131065 (2011).","journal-title":"Hepatology"},{"key":"BFnrgastro2015226_CR37","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1002\/hep.510300527","volume":"30","author":"A Lindblad","year":"1999","unstructured":"Lindblad, A., Glaumann, H. & Strandvik, B. Natural history of liver disease in cystic fibrosis. Hepatology 30, 1151\u20131158 (1999).","journal-title":"Hepatology"},{"key":"BFnrgastro2015226_CR38","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jcf.2011.08.002","volume":"11","author":"CY Ooi","year":"2012","unstructured":"Ooi, C. Y., Nightingale, S., Durie, P. & Freedman, S. D. Ursodeoxycholic acid in cystic fibrosis-associated liver disease. J. Cyst. Fibros. 11, 72\u201373 (2012).","journal-title":"J. Cyst. Fibros."},{"key":"BFnrgastro2015226_CR39","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1471-230X-12-14","volume":"12","author":"W Jin","year":"2012","unstructured":"Jin, W. et al. Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis B-related fibrosis: a leading meta-analysis. BMC Gastroenterol. 12, 14 (2012).","journal-title":"BMC Gastroenterol."},{"key":"BFnrgastro2015226_CR40","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/hep.24105","volume":"53","author":"ZH Lin","year":"2011","unstructured":"Lin, Z. H. et al. Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis. Hepatology 53, 726\u2013736 (2011).","journal-title":"Hepatology"},{"key":"BFnrgastro2015226_CR41","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1002\/hep.28016","volume":"62","author":"DH Leung","year":"2015","unstructured":"Leung, D. H. et al. Aspartate aminotransferase to platelet ratio and fibrosis-4 as biomarkers in biopsy validated pediatric cystic fibrosis liver disease. Hepatology 62, 1576\u20131583 (2015).","journal-title":"Hepatology"},{"key":"BFnrgastro2015226_CR42","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.dld.2012.04.008","volume":"44","author":"T Rath","year":"2012","unstructured":"Rath, T. et al. TIMP-1\/-2 and transient elastography allow non invasive diagnosis of cystic fibrosis associated liver disease. Dig. Liver Dis. 44, 780\u2013787 (2012).","journal-title":"Dig. Liver Dis."},{"issue":"Suppl. 2","key":"BFnrgastro2015226_CR43","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1016\/S1569-1993(11)60006-4","volume":"10","author":"D Debray","year":"2011","unstructured":"Debray, D., Kelly, D., Houwen, R., Strandvik, B. & Colombo, C. Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease. J. Cyst. Fibros. 10 (Suppl. 2), S29\u2013S36 (2011).","journal-title":"J. Cyst. Fibros."},{"key":"BFnrgastro2015226_CR44","first-page":"477","volume":"8","author":"SM O'Brien","year":"1996","unstructured":"O'Brien, S. M. et al. Serum bile acids and ursodeoxycholic acid treatment in cystic fibrosis-related liver disease. Eur. J. Gastroenterol. Hepatol. 8, 477\u2013483 (1996).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"BFnrgastro2015226_CR45","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3109\/00365529709007686","volume":"32","author":"PC van de Meeberg","year":"1997","unstructured":"van de Meeberg, P. C. et al. Low-dose versus high-dose ursodeoxycholic acid in cystic fibrosis-related cholestatic liver disease. Results of a randomized study with 1-year follow-up. Scand. J. Gastroenterol. 32, 369\u2013373 (1997).","journal-title":"Scand. J. Gastroenterol."},{"key":"BFnrgastro2015226_CR46","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1002\/hep.1840150421","volume":"15","author":"C Colombo","year":"1992","unstructured":"Colombo, C. et al. Scintigraphic documentation of an improvement in hepatobiliary excretory function after treatment with ursodeoxycholic acid in patients with cystic fibrosis and associated liver disease. Hepatology 15, 677\u2013684 (1992).","journal-title":"Hepatology"},{"key":"BFnrgastro2015226_CR47","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/hep.23082","volume":"50","author":"KD Lindor","year":"2009","unstructured":"Lindor, K. D. et al. High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis. Hepatology 50, 808\u2013814 (2009).","journal-title":"Hepatology"},{"key":"BFnrgastro2015226_CR48","first-page":"1111","volume":"50","author":"O Pozler","year":"2003","unstructured":"Pozler, O. et al. Transjugular introhepatic portosystemic shunt in five children with cystic fibrosis: long-term results. Hepatogastroenterology 50, 1111\u20131114 (2003).","journal-title":"Hepatogastroenterology"},{"key":"BFnrgastro2015226_CR49","doi-asserted-by":"publisher","first-page":"964597","DOI":"10.1155\/2010\/964597","volume":"2010","author":"JB Lillegard","year":"2010","unstructured":"Lillegard, J. B. et al. A single-institution review of portosystemic shunts in children: an ongoing discussion. HPB Surg. 2010, 964597 (2010).","journal-title":"HPB Surg."},{"key":"BFnrgastro2015226_CR50","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1136\/adc.2006.093773","volume":"91","author":"B Linnane","year":"2006","unstructured":"Linnane, B., Oliver, M. R. & Robinson, P. J. Does splenectomy in cystic fibrosis related liver disease improve lung function and nutritional status? A case series. Arch. Dis. Child. 91, 771\u2013773 (2006).","journal-title":"Arch. Dis. Child."},{"key":"BFnrgastro2015226_CR51","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jcf.2006.10.001","volume":"6","author":"E Aslanidou","year":"2007","unstructured":"Aslanidou, E., Fotoulaki, M., Tsitouridis, I. & Nousia-Arvanitakis, S. Partial splenic embolization: successful treatment of hypersplenism, secondary to biliary cirrhosis and portal hypertension in cystic fibrosis. J. Cyst. Fibros. 6, 212\u2013214 (2007).","journal-title":"J. Cyst. Fibros."},{"key":"BFnrgastro2015226_CR52","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1002\/lt.20465","volume":"11","author":"I Gooding","year":"2005","unstructured":"Gooding, I. et al. Variceal hemorrhage and cystic fibrosis: outcomes and implications for liver transplantation. Liver Transpl. 11, 1522\u20131526 (2005).","journal-title":"Liver Transpl."},{"key":"BFnrgastro2015226_CR53","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/lt.22240","volume":"17","author":"M Mendizabal","year":"2011","unstructured":"Mendizabal, M. et al. Liver transplantation in patients with cystic fibrosis: analysis of United Network for Organ Sharing data. Liver Transpl. 17, 243\u2013250 (2011).","journal-title":"Liver Transpl."},{"key":"BFnrgastro2015226_CR54","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.jcf.2013.12.010","volume":"13","author":"RH Bandsma","year":"2014","unstructured":"Bandsma, R. H. et al. Simultaneous liver-pancreas transplantation for cystic fibrosis-related liver disease: a multicenter experience. J. Cyst. Fibros. 13, 471\u2013477 (2014).","journal-title":"J. Cyst. Fibros."},{"key":"BFnrgastro2015226_CR55","first-page":"247","volume":"110","author":"JR Esterly","year":"1962","unstructured":"Esterly, J. R. & Oppenheimer, E. H. Observations in cystic fibrosis of the pancreas: the gallbladder. Bull. Johns Hopkins Hosp. 110, 247\u2013268 (1962).","journal-title":"Bull. Johns Hopkins Hosp."},{"key":"BFnrgastro2015226_CR56","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/S0168-8278(99)80259-1","volume":"30","author":"I Durieu","year":"1999","unstructured":"Durieu, I. et al. Sclerosing cholangitis in adults with cystic fibrosis: a magnetic resonance cholangiographic prospective study. J. Hepatol. 30, 1052\u20131056 (1999).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2015226_CR57","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jpeds.2007.03.062","volume":"151","author":"H Pall","year":"2007","unstructured":"Pall, H. et al. Primary sclerosing cholangitis in childhood is associated with abnormalities in cystic fibrosis-mediated chloride channel function. J. Pediatr. 151, 255\u2013259 (2007).","journal-title":"J. Pediatr."},{"key":"BFnrgastro2015226_CR58","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/s00439-003-0963-z","volume":"113","author":"S Sheth","year":"2003","unstructured":"Sheth, S. et al. Increased prevalence of CFTR mutations and variants and decreased chloride secretion in primary sclerosing cholangitis. Hum. Genet. 113, 286\u2013292 (2003).","journal-title":"Hum. Genet."},{"key":"BFnrgastro2015226_CR59","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/S0022-3476(89)80134-9","volume":"114","author":"E Kerem","year":"1989","unstructured":"Kerem, E. et al. Clinical and genetic comparisons of patients with cystic fibrosis, with or without meconium ileus. J. Pediatr. 114, 767\u2013773 (1989).","journal-title":"J. Pediatr."},{"key":"BFnrgastro2015226_CR60","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/MPG.0b013e3181a3bfdd","volume":"50","author":"O Efrati","year":"2010","unstructured":"Efrati, O. et al. Meconium ileus in patients with cystic fibrosis is not a risk factor for clinical deterioration and survival: the Israeli Multicenter Study. J. Pediatr. Gastroenterol. Nutr. 50, 173\u2013178 (2010).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"BFnrgastro2015226_CR61","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1053\/j.gastro.2006.07.016","volume":"131","author":"SM Blackman","year":"2006","unstructured":"Blackman, S. M. et al. Relative contribution of genetic and non-genetic modifiers to intestinal obstruction in cystic fibrosis. Gastroenterology 131, 1030\u20131039 (2006).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2015226_CR62","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s00383-011-2906-4","volume":"27","author":"A Karimi","year":"2011","unstructured":"Karimi, A. et al. Issues in the management of simple and complex meconium ileus. Pediatr. Surg. Int. 27, 963\u2013968 (2011).","journal-title":"Pediatr. Surg. Int."},{"key":"BFnrgastro2015226_CR63","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1002\/(SICI)1096-8628(19980806)78:5<446::AID-AJMG9>3.0.CO;2-J","volume":"78","author":"HE Roberts","year":"1998","unstructured":"Roberts, H. E. et al. Increased frequency of cystic fibrosis among infants with jejunoileal atresia. Am. J. Med. Genet. 78, 446\u2013449 (1998).","journal-title":"Am. J. Med. Genet."},{"key":"BFnrgastro2015226_CR64","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s00431-006-0342-6","volume":"166","author":"TH Stollman","year":"2007","unstructured":"Stollman, T. H., Wijnen, R. M. & Draaisma, J. M. Investigation for cystic fibrosis in infants with jejunoileal atresia in the Netherlands: a 35-year experience with 114 cases. Eur. J. Pediatr. 166, 989\u2013990 (2007).","journal-title":"Eur. J. Pediatr."},{"key":"BFnrgastro2015226_CR65","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.1097\/MPG.0b013e3182769768","volume":"58","author":"TS Yap","year":"2014","unstructured":"Yap, T. S., Jiwane, A., Belessis, Y. & Ooi, C. Y. Colonic atresia presenting as neonatal bowel obstruction in cystic fibrosis. J. Pediatr. Gastroenterol. Nutr. 58, e37\u2013e38 (2014).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"BFnrgastro2015226_CR66","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/S1542-3565(04)00169-7","volume":"2","author":"X Dray","year":"2004","unstructured":"Dray, X. et al. Distal intestinal obstruction syndrome in adults with cystic fibrosis. Clin. Gastroenterol. Hepatol. 2, 498\u2013503 (2004).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"BFnrgastro2015226_CR67","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1007\/s11605-009-0924-5","volume":"13","author":"JR Morton","year":"2009","unstructured":"Morton, J. R. et al. Distal intestinal obstruction syndrome (DIOS) in patients with cystic fibrosis after lung transplantation. J. Gastrointest. Surg. 13, 1448\u20131453 (2009).","journal-title":"J. Gastrointest. Surg."},{"key":"BFnrgastro2015226_CR68","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1136\/gut.51.2.285","volume":"51","author":"R Shidrawi","year":"2002","unstructured":"Shidrawi, R. et al. Emergency colonoscopy for distal intestinal obstruction syndrome in cystic fibrosis patients. Gut 51, 285\u2013286 (2002).","journal-title":"Gut"},{"key":"BFnrgastro2015226_CR69","first-page":"72","volume":"22","author":"F Perez-Aguilar","year":"1999","unstructured":"Perez-Aguilar, F. et al. Digestive alterations in cystic fibrosis: retrospective study of a series of 46 adult patients. Gastroenterol. Hepatol. 22, 72\u201378 (1999).","journal-title":"Gastroenterol. Hepatol."},{"key":"BFnrgastro2015226_CR70","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/MPG.0b013e318186d35a","volume":"49","author":"VV Smith","year":"2009","unstructured":"Smith, V. V. et al. Lymphocytic leiomyositis and myenteric ganglionitis are intrinsic features of cystic fibrosis: studies in distal intestinal obstruction syndrome and meconium ileus. J. Pediatr. Gastroenterol. Nutr. 49, 42\u201351 (2009).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"BFnrgastro2015226_CR71","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/MPG.0b013e3181a6e01d","volume":"50","author":"RH Houwen","year":"2010","unstructured":"Houwen, R. H. et al. Defining DIOS and constipation in cystic fibrosis with a multicentre study on the incidence, characteristics, and treatment of DIOS. J. Pediatr. Gastroenterol. Nutr. 50, 38\u201342 (2010).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"BFnrgastro2015226_CR72","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1148\/rg.263055101","volume":"26","author":"MD Robertson","year":"2006","unstructured":"Robertson, M. D., Choe, K. A. & Joseph, P. M. Review of the abdominal manifestations of cystic fibrosis in the adult patient. Radiographics 26, 679\u2013690 (2006).","journal-title":"Radiographics"},{"key":"BFnrgastro2015226_CR73","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1136\/adc.66.3.307","volume":"66","author":"MD Shields","year":"1991","unstructured":"Shields, M. D. et al. Appendicitis in cystic fibrosis. Arch. Dis. Child. 66, 307\u2013310 (1991).","journal-title":"Arch. Dis. Child."},{"key":"BFnrgastro2015226_CR74","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1148\/radiol.2321030363","volume":"232","author":"SW Lardenoye","year":"2004","unstructured":"Lardenoye, S. W., Puylaert, J. B., Smit, M. J. & Holscher, H. C. Appendix in children with cystic fibrosis: US features. Radiology 232, 187\u2013189 (2004).","journal-title":"Radiology"},{"key":"BFnrgastro2015226_CR75","first-page":"948367","volume":"2012","author":"JM Lee","year":"2012","unstructured":"Lee, J. M. et al. Update of faecal markers of inflammation in children with cystic fibrosis. Mediators Inflamm. 2012, 948367 (2012).","journal-title":"Mediators Inflamm."},{"key":"BFnrgastro2015226_CR76","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1007\/s10620-015-3842-2","volume":"60","author":"CY Ooi","year":"2015","unstructured":"Ooi, C. Y. et al. Fecal human \u03b2-defensin 2 in children with cystic fibrosis: is there a diminished intestinal innate immune response? Dig. Dis. Sci. 60, 2946\u20132952 (2015).","journal-title":"Dig. Dis. Sci."},{"key":"BFnrgastro2015226_CR77","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.jpeds.2015.02.049","volume":"167","author":"AG Hoen","year":"2015","unstructured":"Hoen, A. G. et al. Associations between gut microbial colonization in early life and respiratory outcomes in cystic fibrosis. J. Pediatr. 167, 138\u2013147 (2015).","journal-title":"J. Pediatr."},{"key":"BFnrgastro2015226_CR78","doi-asserted-by":"publisher","first-page":"e61176","DOI":"10.1371\/journal.pone.0061176","volume":"8","author":"S Schippa","year":"2013","unstructured":"Schippa, S. et al. Cystic fibrosis transmembrane conductance regulator (CFTR) allelic variants relate to shifts in fecal microbiota of cystic fibrosis patients. PLoS ONE 8, e61176 (2013).","journal-title":"PLoS ONE"},{"key":"BFnrgastro2015226_CR79","doi-asserted-by":"publisher","first-page":"e87796","DOI":"10.1371\/journal.pone.0087796","volume":"9","author":"E Bruzzese","year":"2014","unstructured":"Bruzzese, E. et al. Disrupted intestinal microbiota and intestinal inflammation in children with cystic fibrosis and its restoration with Lactobacillus GG: a randomised clinical trial. PLoS ONE 9, e87796 (2014).","journal-title":"PLoS ONE"},{"key":"BFnrgastro2015226_CR80","doi-asserted-by":"publisher","first-page":"8015","DOI":"10.1128\/AEM.05933-11","volume":"77","author":"G Duytschaever","year":"2011","unstructured":"Duytschaever, G. et al. Cross-sectional and longitudinal comparisons of the predominant fecal microbiota compositions of a group of pediatric patients with cystic fibrosis and their healthy siblings. Appl. Environ. Microbiol. 77, 8015\u20138024 (2011).","journal-title":"Appl. Environ. Microbiol."},{"key":"BFnrgastro2015226_CR81","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.jcf.2012.03.007","volume":"11","author":"PD Scanlan","year":"2012","unstructured":"Scanlan, P. D. et al. Gut dysbiosis in cystic fibrosis. J. Cyst. Fibros. 11, 454\u2013455 (2012).","journal-title":"J. Cyst. Fibros."},{"key":"BFnrgastro2015226_CR82","doi-asserted-by":"publisher","first-page":"e00251","DOI":"10.1128\/mBio.00251-12","volume":"3","author":"JC Madan","year":"2012","unstructured":"Madan, J. C. et al. Serial analysis of the gut and respiratory microbiome in cystic fibrosis in infancy: interaction between intestinal and respiratory tracts and impact of nutritional exposures. mBio 3, e00251\u201312 (2012).","journal-title":"mBio"},{"key":"BFnrgastro2015226_CR83","doi-asserted-by":"publisher","first-page":"G104","DOI":"10.1152\/ajpgi.00548.2006","volume":"293","author":"RC De Lisle","year":"2007","unstructured":"De Lisle, R. C. Altered transit and bacterial overgrowth in the cystic fibrosis mouse small intestine. Am. J. Physiol. Gastrointest. Liver Physiol. 293, G104\u2013G111 (2007).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"BFnrgastro2015226_CR84","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1155\/2011\/604643","volume":"25","author":"BA Malik","year":"2011","unstructured":"Malik, B. A., Xie, Y. Y., Wine, E. & Huynh, H. Q. Diagnosis and pharmacological management of small intestinal bacterial overgrowth in children with intestinal failure. Can. J. Gastroenterol. 25, 41\u201345 (2011).","journal-title":"Can. J. Gastroenterol."},{"key":"BFnrgastro2015226_CR85","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.jcf.2014.02.007","volume":"13","author":"R del Campo","year":"2014","unstructured":"del Campo, R. et al. Improvement of digestive health and reduction in proteobacterial populations in the gut microbiota of cystic fibrosis patients using a Lactobacillus reuteri probiotic preparation: a double blind prospective study. J. Cyst. Fibros. 13, 716\u2013722 (2014).","journal-title":"J. Cyst. Fibros."},{"key":"BFnrgastro2015226_CR86","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1093\/infdis\/148.1.176","volume":"148","author":"TC Wu","year":"1983","unstructured":"Wu, T. C., McCarthy, V. P. & Gill, V. J. Isolation rate and toxigenic potential of Clostridium difficile isolates from patients with cystic fibrosis. J. Infect. Dis. 148, 176 (1983).","journal-title":"J. Infect. Dis."},{"key":"BFnrgastro2015226_CR87","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0022-3476(98)70511-6","volume":"132","author":"J Rivlin","year":"1998","unstructured":"Rivlin, J. et al. Severe Clostridium difficile-associated colitis in young patients with cystic fibrosis. J. Pediatr. 132, 177\u2013179 (1998).","journal-title":"J. Pediatr."},{"key":"BFnrgastro2015226_CR88","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/S0022-3476(88)80166-5","volume":"112","author":"DM Roberts","year":"1988","unstructured":"Roberts, D. M. et al. Prevalence of giardiasis in patients with cystic fibrosis. J. Pediatr. 112, 555\u2013559 (1988).","journal-title":"J. Pediatr."},{"key":"BFnrgastro2015226_CR89","doi-asserted-by":"publisher","first-page":"6040","DOI":"10.1128\/IAI.72.10.6040-6049.2004","volume":"72","author":"O Norkina","year":"2004","unstructured":"Norkina, O., Burnett, T. G. & De Lisle, R. C. Bacterial overgrowth in the cystic fibrosis transmembrane conductance regulator null mouse small intestine. Infect. Immun. 72, 6040\u20136049 (2004).","journal-title":"Infect. Immun."},{"key":"BFnrgastro2015226_CR90","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1136\/adc.82.5.394","volume":"82","author":"RL Smyth","year":"2000","unstructured":"Smyth, R. L. et al. Intestinal inflammation in cystic fibrosis. Arch. Dis. Child. 82, 394\u2013399 (2000).","journal-title":"Arch. Dis. Child."},{"key":"BFnrgastro2015226_CR91","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/MPG.0b013e3181d1b013","volume":"51","author":"SL Werlin","year":"2010","unstructured":"Werlin, S. L. et al. Evidence of intestinal inflammation in patients with cystic fibrosis. J. Pediatr. Gastrtroenterol. Nutr. 51, 304\u2013308 (2010).","journal-title":"J. Pediatr. Gastrtroenterol. Nutr."},{"key":"BFnrgastro2015226_CR92","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1111\/j.1365-2036.2004.02174.x","volume":"20","author":"E Bruzzese","year":"2004","unstructured":"Bruzzese, E., Raia, V. & Gaudiello, G. Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration. Aliment. Pharmacol. Ther. 20, 813\u2013819 (2004).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro2015226_CR93","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1097\/MPG.0000000000000683","volume":"60","author":"J Dhaliwal","year":"2015","unstructured":"Dhaliwal, J. et al. Intestinal inflammation and impact on growth in children with cystic fibrosis. J. Pediatr. Gastrtroenterol. Nutr. 60, 521\u2013526 (2015).","journal-title":"J. Pediatr. Gastrtroenterol. Nutr."},{"key":"BFnrgastro2015226_CR94","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1111\/jgh.12842","volume":"30","author":"T Pang","year":"2015","unstructured":"Pang, T. et al. Elevated faecal M2-pyruvate kinase in children with cystic fibrosis: a clue to the increased risk of intestinal malignancy in adulthood? J. Gastroenterol. Hepatol. 30, 866\u2013871 (2015).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"BFnrgastro2015226_CR95","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3109\/00365513.2010.486869","volume":"70","author":"A Lisowska","year":"2010","unstructured":"Lisowska, A. et al. Small intestine bacterial overgrowth does not correspond to intestinal inflammation in cystic fibrosis. Scand. J. Clin. Lab. Invest. 70, 322\u2013326 (2010).","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"BFnrgastro2015226_CR96","doi-asserted-by":"publisher","first-page":"e85","DOI":"10.1097\/MCG.0000000000000034","volume":"48","author":"JL Billings","year":"2014","unstructured":"Billings, J. L. et al. Early colon screening of adult patients with cystic fibrosis reveals high incidence of adenomatous colon polyps. J. Clin. Gastroenterol. 48, e85\u201388 (2014).","journal-title":"J. Clin. Gastroenterol."},{"key":"BFnrgastro2015226_CR97","doi-asserted-by":"publisher","first-page":"G681","DOI":"10.1152\/ajpcell.2001.281.2.C681","volume":"281","author":"AM Gallagher","year":"2001","unstructured":"Gallagher, A. M. & Gottlieb, R. A. Proliferation, not apoptosis, alters epithelial cell migration in small intestine of CFTR null mice. Am. J. Physiol. Gastroenterol. 281, G681\u2013G687 (2001).","journal-title":"Am. J. Physiol. Gastroenterol."},{"key":"BFnrgastro2015226_CR98","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1038\/sj.bjc.6602033","volume":"91","author":"PD Hardt","year":"2004","unstructured":"Hardt, P. D. et al. Faecal tumour M2 pyruvate kinase: a new, sensitive screening tool for colorectal cancer. Br. J. Cancer 91, 980\u2013984 (2004).","journal-title":"Br. J. Cancer"},{"key":"BFnrgastro2015226_CR99","doi-asserted-by":"publisher","first-page":"3587","DOI":"10.1073\/pnas.93.8.3587","volume":"93","author":"RA Gottlieb","year":"1996","unstructured":"Gottlieb, R. A., Dosanjh, A. Mutant cystic fibrosis transmembrane conductance regulator inhibits acidification and apoptosis in C127 cells: possible relevance to cystic fibrosis. Proc. Natl Acad. Sci. USA 93, 3587\u20133591 (1996).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrgastro2015226_CR100","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s11010-008-9815-4","volume":"316","author":"A Mehta","year":"2008","unstructured":"Mehta, A. Cystic fibrosis as a bowel cancer syndrome and the potential role of CK2. Mol. Cell. Biochem. 316, 169\u2013175 (2008).","journal-title":"Mol. Cell. Biochem."},{"key":"BFnrgastro2015226_CR101","doi-asserted-by":"publisher","first-page":"G7","DOI":"10.1152\/ajpgi.00079.2004","volume":"287","author":"SH Itzkowitz","year":"2004","unstructured":"Itzkowitz, S. H. & Yio, X. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 287, G7\u2013G17 (2004).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"BFnrgastro2015226_CR102","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/ppul.21524","volume":"47","author":"M Doumit","year":"2012","unstructured":"Doumit, M., Krishnan, U., Jaff\u00e9, A. & Belessis, Y. Acid and non-acid reflux during physiotherapy in young children with cystic fibrosis. Pediatr. Pulmonol. 47, 119\u2013124 (2012).","journal-title":"Pediatr. Pulmonol."},{"key":"BFnrgastro2015226_CR103","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1111\/j.1365-2036.2011.04786.x","volume":"34","author":"A Pauwels","year":"2011","unstructured":"Pauwels, A. et al. Gastric emptying and different types of reflux in adult patients with cystic fibrosis. Aliment. Pharmacol. Ther. 34, 799\u2013807 (2011).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro2015226_CR104","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1016\/j.healun.2004.11.312","volume":"24","author":"BM Button","year":"2005","unstructured":"Button, B. M. et al. Gastroesophageal reflux (symptomatic and silent): a potentially significant problem in patients with cystic fibrosis before and after lung transplantation. J. Heart Lung Transplant. 24, 1522\u20131529 (2005).","journal-title":"J. Heart Lung Transplant."},{"key":"BFnrgastro2015226_CR105","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0140-6736(94)90817-6","volume":"343","author":"RL Smythe","year":"1994","unstructured":"Smythe, R. L. et al. Strictures of ascending colon in cystic fibrosis and high strength pancreatic enzymes. Lancet 343, 85\u201386 (1994).","journal-title":"Lancet"},{"key":"BFnrgastro2015226_CR106","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/S0022-3476(95)70153-2","volume":"127","author":"DS Borowitz","year":"1995","unstructured":"Borowitz, D. S., Grand, R. J. & Durie, P. R. Use of pancreatic enzyme supplements for patients with cystic fibrosis in the context of fibrosing colonopathy. J. Pediatr. 127, 681\u2013684 (1995).","journal-title":"J. Pediatr."},{"key":"BFnrgastro2015226_CR107","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1097\/00005176-200209000-00004","volume":"35","author":"D Borowitz","year":"2002","unstructured":"Borowitz, D., Baker, R. D. & Stallings, V. Consensus report on nutrition for pediatric patients with cystic fibrosis. J. Pediatr. Gastroenterol. Nutr. 35, 246\u2013259 (2002).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"BFnrgastro2015226_CR108","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1007\/BF02087437","volume":"39","author":"JD Lloyd-Still","year":"1994","unstructured":"Lloyd-Still, J. D. Crohn's disease and cystic fibrosis. Dig. Dis. Sci. 39, 880\u2013885 (1994).","journal-title":"Dig. Dis. Sci."},{"key":"BFnrgastro2015226_CR109","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1002\/ibd.20067","volume":"13","author":"F Bresso","year":"2007","unstructured":"Bresso, F. et al. Potential role for the common cystic fibrosis \u0394F508 mutation in Crohn's disease. Inflamm. Bowel Dis. 13, 531\u2013536 (2007).","journal-title":"Inflamm. Bowel Dis."},{"key":"BFnrgastro2015226_CR110","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.jcf.2010.03.010","volume":"9","author":"S Bahmanyar","year":"2010","unstructured":"Bahmanyar, S. et al. Cystic fibrosis gene mutations and gastrointestinal diseases. J. Cyst. Fibros. 9, 288\u2013291 (2010).","journal-title":"J. Cyst. Fibros."},{"key":"BFnrgastro2015226_CR111","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.jcf.2010.10.006","volume":"10","author":"F Bresso","year":"2011","unstructured":"Bresso, F., D'Amato, M. The cystic fibrosis F508del mutation in Crohn's disease. J. Cyst. Fibros. 10, 132 (2011).","journal-title":"J. Cyst. Fibros."},{"key":"BFnrgastro2015226_CR112","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1164\/rccm.201404-0703OC","volume":"190","author":"SM Rowe","year":"2014","unstructured":"Rowe, S. M. et al. Clinical mechanism of the cystic fibrosis transmembrane conductance regulator potentiator ivacaftor in G551D-mediated cystic fibrosis. Am. J. Respir. Crit. Care Med. 190, 175\u2013184 (2014).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"BFnrgastro2015226_CR113","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1056\/NEJMc1213681","volume":"369","author":"MJ Harrison","year":"2013","unstructured":"Harrison, M. J., Murphy, D. M. & Plant, B. J. Ivacaftor in a G551D homozygote with cystic fibrosis. N. Engl. J. Med. 369, 1280\u20131282 (2013).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro2015226_CR114","first-page":"475","volume":"55","author":"G Fallahi","year":"2013","unstructured":"Fallahi, G. et al. The effect of probiotics on fecal calprotectin in patients with cystic fibrosis. Turk. J. Pediatr. 55, 475\u2013478 (2013).","journal-title":"Turk. J. Pediatr."},{"key":"BFnrgastro2015226_CR115","first-page":"669","volume":"23","author":"SA Jafari","year":"2013","unstructured":"Jafari, S. A. et al. Effects of probiotics on quality of life in children with cystic fibrosis; a randomized controlled trial. Iran. J. Pediatr. 23, 669\u2013674 (2013).","journal-title":"Iran. J. Pediatr."},{"key":"BFnrgastro2015226_CR116","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.clnu.2007.01.004","volume":"26","author":"E Bruzzese","year":"2007","unstructured":"Bruzzese, E. et al. Effect of Lactobacillus GG supplementation on pulmonary exacerbations in patients with cystic fibrosis: a pilot study. Clin. Nutr. 26, 322\u2013328 (2007).","journal-title":"Clin. Nutr."},{"key":"BFnrgastro2015226_CR117","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/ppul.21138","volume":"45","author":"B Weiss","year":"2010","unstructured":"Weiss, B. et al. Probiotic supplementation affects pulmonary exacerbations in patients with cystic fibrosis: a pilot study. Pediatr. Pulmonol. 45, 536\u2013540 (2010).","journal-title":"Pediatr. Pulmonol."},{"key":"BFnrgastro2015226_CR118","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1053\/j.gastro.2004.07.006","volume":"127","author":"S Hirtz","year":"2004","unstructured":"Hirtz, S. et al. CFTR Cl\u2212 channel function in native human colon correlates with the genotype and phenotype in cystic fibrosis. Gastroenterology 127, 1085\u20131095 (2004).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2015226_CR119","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/0016-5085(91)90017-F","volume":"101","author":"HJ Veeze","year":"1991","unstructured":"Veeze, H. J. et al. Ion transport abnormalities in rectal suction biopsies from children with cystic fibrosis. Gastroenterology 101, 398\u2013403 (1991).","journal-title":"Gastroenterology"},{"issue":"Suppl. 2","key":"BFnrgastro2015226_CR120","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.jcf.2004.05.035","volume":"3","author":"M Mall","year":"2004","unstructured":"Mall, M., Hirtz, S., Gonska, T. & Kunzelmann, K. Assessment of CFTR function in rectal biopsies for the diagnosis of cystic fibrosis. J. Cyst. Fibros. 3 (Suppl. 2), 165\u2013169 (2004).","journal-title":"J. Cyst. Fibros."},{"key":"BFnrgastro2015226_CR121","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/nm.3201","volume":"19","author":"JF Dekkers","year":"2013","unstructured":"Dekkers, J. F. et al. A functional CFTR assay using primary cystic fibrosis intestinal organoids. Nat. Med. 19, 939\u2013945 (2013).","journal-title":"Nat. Med."},{"key":"BFnrgastro2015226_CR122","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0009-8981(99)00206-5","volume":"292","author":"H T\u00f8n","year":"2000","unstructured":"T\u00f8n, H. et al. Improved assay for fecal calprotectin. Clin. Chim. Acta 292, 41\u201354 (2000).","journal-title":"Clin. Chim. Acta"}],"container-title":["Nature Reviews Gastroenterology &amp; Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2015.226.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2015.226","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2015.226.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T23:53:38Z","timestamp":1684454018000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2015.226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,21]]},"references-count":122,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["BFnrgastro2015226"],"URL":"https:\/\/doi.org\/10.1038\/nrgastro.2015.226","relation":{},"ISSN":["1759-5045","1759-5053"],"issn-type":[{"value":"1759-5045","type":"print"},{"value":"1759-5053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,21]]},"assertion":[{"value":"21 January 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.Y.O. received consultancy fees from Vertex. P.R.D. declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}